advertiser banner advertiser banner
Digital Issues

Home >  News >  February, 2014

Local Analgesic Reduces Post-Bariatric Opioids

Study explores Exparel's use in managing abdominal surgery pain.

Published: February 3, 2014

A multimodal pain management therapy that includes the non-opioid local analgesic Exparel lessens the need for post-op narcotics after bariatric surgery, according to a recent study.

For the study, Andras Sandor, MD, FACS, FASMBS, and colleagues at the Hallmark Health Center for Weight Management and Weight Loss Surgery in Medford, Mass., observed the pain management regimens of 90 patients undergoing laparoscopic bariatric procedures.

Half of the patients received a multimodal approach to post-op pain management, including Pacira Pharmaceutical's bupivacaine liposome injectable suspension drug, Exparel, infiltrated into the transversus abdominis plane (a process known as iTAP). The other half were given ketorolac and a lidocaine and bupivacaine/epinephrine combination perioperatively, and pain pumps of hydromorphone afterward.

Each group was allowed opioids at 2 days post-op. But the multimodal group consumed 60.7% fewer opioids. Additionally, they exhibited a greater return of bowel function at the 2-day mark. Dr. Sandor and his team presented their findings at the American Society for Metabolic & Bariatric Surgery's 2013 Obesity Week in November.

"The risks of opioids are pronounced in the bariatric population; utilizing a non-opioid platform with Exparel iTAP at its foundation contributed to decreasing both the amount of opioids needed and their resultant opioid-related adverse effects," says Dr. Sandor.

David Bernard


Also in the News...

Morphine Following Common Childhood Surgery May Be Life Threatening
Outbreak at Seattle Hospital Infects at Least 35, Suspected in 11 Deaths
Unfiltered OR Lights Burn Patients at Oregon Hospital
Wyoming ASCs' Recovery Care Proposal Iced
UPDATE: Boston Hospital Surgeon Dies After Shooting
Court Overturns $12 Million Defamation Judgment Against Plastic Surgery Patient
Yorkville Endoscopy Loses AAAASF Accreditation

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
Infection Control

Bioburden Doesn't Stand a Chance

advertiser banner

Other Articles That May Interest You

Anesthesia Alert: Give Your Pain Service a Shot of Efficiency

10 tips for treating chronic pain more quickly, safely and profitably.

A Better Option for Pediatric Post-Op Pain?

The Surgeons' Lounge: Pain Control

Should We Switch to Non-Opioid IV Pain Meds?